Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Rapid Control Interventions Key In Preventing Ebola Spread

October 10, 2014 By AxoGen, Inc.

New Ebola research demonstrates that quick and forceful implementation of control interventions are necessary to control outbreaks and avoid far worse scenarios.

Researchers analyzed up-to-date epidemiological data of Ebola cases in Nigeria as of Oct. 1, 2014, in order to estimate the case fatality rate, proportion of health care workers infected, transmission progression and impact of control interventions on the size of the epidemic.

“Rapid and forceful control measures are necessary as is demonstrated by the Nigerian success story. This is critically important for countries in the West African region that are not yet affected by the Ebola epidemic, as well as for countries in other regions of the world that risk importation of the disease,” said Arizona State University’s Gerardo Chowell, senior author of the research and associate professor in the School of Human Evolution and Social Change in the College of Liberal Arts and Sciences.

The largest Ebola outbreak to date is ongoing in West Africa with approximately 8,011 reported cases including more than 3,857 deaths as of Oct. 5. Twenty Ebola cases have been reported in Nigeria, with no new cases reported since September 5, 2014. All of the cases stem from a single traveler returning from Liberia in July.

For the paper, “Transmission dynamics and control of Ebola Virus Disease (EVD) outbreak in Nigeria, July-September, 2014,” published today in Eurosurveillance, researchers used epidemic modeling to project the size of the outbreak in Nigeria if control interventions had been implemented during various time periods after the initial case and estimated how many cases had thus been prevented by early initiation of interventions.

Control measures enacted in Nigeria included all people showing Ebola symptoms being held in an isolation ward if they had contact with the initial case. Once Ebola was confirmed through testing, people with Ebola were moved to a treatment center.

Asymptomatic individuals were separated from those showing symptoms and those who tested negative without symptoms were discharged. People who tested negative, but showed symptoms – fever, vomiting, sore throat and diarrhea – were observed and discharged after 21 days if they were free of symptoms, while being kept apart from people who tested positive for the disease.

“The swift control of the outbreak in Nigeria was likely facilitated by early detection of the initial case in combination with intense tracing efforts of all subsequent contacts that the person had after developing Ebola,” said Folorunso Oludayo Fasina, a senior scientist and lead author of the study at the University of Pretoria, South Africa. “By contrast, the initial outbreak in Guinea remained undetected for several weeks, facilitating the spread of the virus to Sierra Leone and Liberia where the inability to track and contain infectious individuals compounded the situation and resulted in an uncontrolled epidemic.”

Ebola transmission is dramatically influenced by how rapidly control measures are put in place, as researchers found that the projected effect of control interventions in Nigeria ranged from 15-106 cases when interventions are put in place on day 3; 20-178 cases when implemented on day 10; 23-282 cases on day 20; 60-666 cases on day 30; 39-1599 cases on day 40; and 93-2771 on day 50.

“There is brief window of time when a rapid and forceful intervention in terms of relentless contact tracing and isolation pays off handsomely and the transmission is effectively halted and the outbreak dies out,” said co-author Professor Lone Simonsen, of the Milken Institute School of Public Health at the George Washington University in Washington D.C.

The person who was initially infected generated 12 secondary cases, in the first generation of the disease; 5 secondary cases were generated from those 12 in the second generation; and 2 secondary cases in the third generation, leading to a rough empirical estimate of the reproduction number according to disease generation declining from 12 during the first generation, to approximately 0.4 during the second and third disease generations. Recent estimates of the reproduction number for the ongoing Ebola epidemic in Sierra Leone and Liberia range between 1.5 and 2 (two new cases for each single case), indicating that the outbreak is yet to be brought under control.

“The effectiveness of the Nigerian response is illustrated by a dramatic decrease in the number of secondary cases over time. Overall, this is a great success story for Nigeria, which sets a hopeful example for other countries, including the U.S., which face risk of importation from high Ebola transmission areas,” said Dr. Cécile Viboud, a National Institutes of Health scientist with the Fogarty International Center.

Related Articles Read More >

This is a Zimmer Biomet marketing image of its Rosa robotic surgery system.
Zimmer Biomet seeks a ZBEdge for its Rosa robotic surgery
A photo of Capstan Medical's mitral valve implant, which uses nitinol.
Capstan Medical’s R&D head discusses the heart valve and robotics startup’s tech, engineering challenges and solutions, advice for others in medtech and how to join his team
An illustration of a neurosurgeon using a robotic endoscope to remove a brain tumor.
MDO Nitinol Innovation Special Report
A photo of Highridge Medical CEO Rebecca Whitney.
Highridge Medical is betting on this spine tech
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe